XGEN PHARMS FDA Approval ANDA 065220

ANDA 065220

XGEN PHARMS

FDA Drug Application

Application #065220

Application Sponsors

ANDA 065220XGEN PHARMS

Marketing Status

Prescription001

Application Products

001TABLET;ORAL500MG0NEOMYCIN SULFATENEOMYCIN SULFATE

FDA Submissions

ORIG1AP2006-07-28

TE Codes

001PrescriptionAA

CDER Filings

XGEN PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 65220
            [companyName] => XGEN PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"NEOMYCIN SULFATE","activeIngredients":"NEOMYCIN SULFATE","strength":"500MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"NEOMYCIN SULFATE","submission":"NEOMYCIN SULFATE","actionType":"500MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.